Saturday, August 31, 2019 8:00:27 PM
Public or not, GRN Funds needs a licensed financial advisor because of what they do
"Financial Analysis
Evaluating businesses, projects, and budgets to determine their performance and suitability. Typically, financial analysis is used to analyze whether an entity is stable, solvent, liquid or profitable enough to warrant investment."
"Consulting
Planning for your financial future by offering information and guidance on topics that include taxes, investments and insurance decisions. We work closely with you to offer personalized financial advice."
https://grnfunds.com/#about
Washington state doesn't allow a "private fund manager exemption."
"Unlike federal law, Washington law does not have a private adviser exemption"
https://dfi.wa.gov/documents/investment-advisers/notice-hedge-fund-managers.pdf
They require registration through FINRA and the SEC
"The Washington State Department of Financial Institutions Securities Division mandates applicants for investment adviser registration use the Investment Adviser Registration Depository (IARD).
The IARD is a national computer database operated by the Financial Industry Regulatory Authority (FINRA) and is used by the states and the Securities and Exchange Commission for registration purposes.
Applicants will partially file electronically through the IARD system and partially file on paper with the Washington State Securities Division. All applications for investment adviser representative registration must be filed on IARD."
https://dfi.wa.gov/investment-advisers/registration
FINRA IARD
https://www.iard.com/
Find financial advisors here
https://fortress.wa.gov/dfi/webapp/dfi/EFiling/LicenseLookUp
"Investment advisers and their representatives operating in Washington (with certain exceptions) are required to be licensed with the Securities Division. Persons who provide investment portfolio management for their clients or who hold themselves out to the public as financial planners are among those required to be licensed."
https://dfi.wa.gov/investment-advisers
"Financial Analysis
Evaluating businesses, projects, and budgets to determine their performance and suitability. Typically, financial analysis is used to analyze whether an entity is stable, solvent, liquid or profitable enough to warrant investment."
"Consulting
Planning for your financial future by offering information and guidance on topics that include taxes, investments and insurance decisions. We work closely with you to offer personalized financial advice."
https://grnfunds.com/#about
Washington state doesn't allow a "private fund manager exemption."
"Unlike federal law, Washington law does not have a private adviser exemption"
https://dfi.wa.gov/documents/investment-advisers/notice-hedge-fund-managers.pdf
They require registration through FINRA and the SEC
"The Washington State Department of Financial Institutions Securities Division mandates applicants for investment adviser registration use the Investment Adviser Registration Depository (IARD).
The IARD is a national computer database operated by the Financial Industry Regulatory Authority (FINRA) and is used by the states and the Securities and Exchange Commission for registration purposes.
Applicants will partially file electronically through the IARD system and partially file on paper with the Washington State Securities Division. All applications for investment adviser representative registration must be filed on IARD."
https://dfi.wa.gov/investment-advisers/registration
FINRA IARD
https://www.iard.com/
Find financial advisors here
https://fortress.wa.gov/dfi/webapp/dfi/EFiling/LicenseLookUp
"Investment advisers and their representatives operating in Washington (with certain exceptions) are required to be licensed with the Securities Division. Persons who provide investment portfolio management for their clients or who hold themselves out to the public as financial planners are among those required to be licensed."
https://dfi.wa.gov/investment-advisers
Recent MAJI News
- NexTel Medical Corp Announces Pivotal Milestone in Commercial Launch of Patent-Protected NANOG DNA Cancer Screening Test • GlobeNewswire Inc. • 04/07/2026 02:30:00 PM
- Form QUALIF - Notice of Qualification [Regulation A] • Edgar (US Regulatory) • 03/30/2026 04:15:02 AM
- Form 253G1 - • Edgar (US Regulatory) • 03/27/2026 07:12:08 PM
- Form 1-A POS - • Edgar (US Regulatory) • 03/26/2026 08:25:15 PM
- Form 1-A POS - • Edgar (US Regulatory) • 03/20/2026 08:23:33 PM
- Exousia Pro, Inc. Announces Favorable Litigation Settlement, Highlighting Significant Debt Elimination and Share Cancellation to Enhance Shareholder Value • GlobeNewswire Inc. • 03/16/2026 02:15:00 PM
- Form 1-A POS - • Edgar (US Regulatory) • 03/11/2026 07:11:39 PM
- Exousia Pro, Inc. Announces Strategic Elimination of Future Dilutive Issuance of 47 Million Shares, Progresses Toward Definitive Agreements for Telehealth Acquisitions • GlobeNewswire Inc. • 03/05/2026 06:00:20 PM
- Form 1-A POS - • Edgar (US Regulatory) • 02/19/2026 09:39:04 PM
- Form 253G2 - • Edgar (US Regulatory) • 02/11/2026 08:06:08 PM
- Exousia Pro, Inc. Accelerates Strategic Expansion with Third Telehealth Acquisition; Strengthens Pathway to Low-Cost Customer Acquisition • GlobeNewswire Inc. • 02/10/2026 03:30:00 PM
- Form 253G2 - • Edgar (US Regulatory) • 01/15/2026 06:47:01 PM
- Form 253G1 - • Edgar (US Regulatory) • 01/14/2026 09:54:45 PM
- Form 1-A POS - • Edgar (US Regulatory) • 12/31/2025 12:32:47 PM
- Form 253G2 - • Edgar (US Regulatory) • 12/29/2025 08:29:49 PM
- Exousia Pro, Inc. Announces Executed LOI for Strategic Acquisition of High-Revenue Telehealth Platform to Accelerate Nutraceutical Commercialization • ACCESS Newswire • 12/11/2025 05:15:00 PM
- Exousia Pro, Inc. Revolutionizes Nutraceuticals With Launch Of Maxasome(TM): The First All-Natural, Biologically Active Exosomal Supplement • ACCESS Newswire • 12/05/2025 04:00:00 PM
- Form 253G2 - • Edgar (US Regulatory) • 12/04/2025 09:35:28 PM
- Exousia Pro, Inc. Completes Exclusive Licensing Agreement With the University of Central Florida for Novel Cancer Diagnostic and Therapy Platforms • ACCESS Newswire • 12/02/2025 06:45:00 PM
- Exousia Pro Initiates Strategic Realignment, Acquires Controlling Stake in SEC-Reporter Lamy (LMMY) in All-stock Exchange Transaction for Exousia AI, to Advance Growth and Enhance Shareholder Value • ACCESS Newswire • 11/17/2025 08:40:00 PM
- Exousia Pro Announces Breakthrough In Exosome-Based Delivery • ACCESS Newswire • 11/04/2025 03:40:00 PM
- Exousia Pro is Excited to Announce that it has Received Orphan Drug Designation from the FDA • ACCESS Newswire • 10/28/2025 02:20:00 PM
- Exousia Pro Announces Groundbreaking Study to Revolutionize the Global Edibles Market with CBD-Loaded Exosomes • ACCESS Newswire • 09/29/2025 04:35:00 PM
- Exousia Pro Reports Positive Outcome in Legal Proceeding • ACCESS Newswire • 09/26/2025 02:30:00 PM

